Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD3 is a **multimeric protein complex and T cell co-receptor**, composed of four invariant transmembrane chains: CD3ε (epsilon), CD3γ (gamma), CD3δ (delta), and CD3ζ (zeta)[4][3]. These assemble as heterodimers (CD3γε, CD3δε) plus a ζζ homodimer, and associate noncovalently with the antigen-specific T cell receptor (TCR), either αβ or γδ[5][6][8]. CD3 is essential for **T cell activation**: it transduces signals from the TCR after antigen recognition by its intracellular Immunoreceptor Tyrosine-based Activation Motifs (ITAMs)[4][2][3]. The complex is a **key marker of T cell lineage**, extensively used in diagnosis and as a therapeutic target. Engagement of CD3 with agonist or antagonist antibodies profoundly modulates T cell function—leading to its clinical use in immunosuppression (e.g., transplant rejection, type 1 diabetes) and as a point of therapeutic redirection in cancer immunotherapy[5][7]. CD3 is also a **crucial component in structurally stabilizing the TCR complex** and organizing activation signals, with its structure and signaling mechanisms being the focus of extensive immunological research[4][5][6].
Antibody-mediated receptor modulation (e.g., anti-CD3 antibodies bind CD3, alter T cell activation, induce cell depletion or immunomodulation) Signal transduction inhibition or activation (by modulating TCR signaling through CD3 engagement) Immunosuppressive cytotoxicity (depletion of T cells via complement- and cell-mediated cytotoxicity, especially with murine antibodies) T cell redirection (bispecific T cell engagers, CAR-T)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell antigen CD3 (CD3).